You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

NIH Office of AIDS Research Looks at Aging with HIV

SUMMARY
The National Institutes of Health's Office of AIDS Research (OAR) recently held a meeting of experts to review information about HIV and aging and formulate a research agenda.

As people with HIV live longer thanks to effective combination antiretroviral therapy (ART), conditions associated with aging have become a greater concern. A growing body of evidence indicates that HIV positive people tend to develop cardiovascular disease and neurocognitive impairment at younger ages, and also appear to experience accelerated immune system aging, or immune senescence.

The National AIDS Treatment Advocacy Project (NATAP) has made slide presentations from the meeting available at [www.natap.org/2011/HIV/042511_01.htm].

The topics featured in the slides include atherosclerosis, frailty and inflammation, HIV and accelerated aging, the aging kidney, aging and the neurological system, immune senescence, the biology of immune aging, and HIV comorbidity and toxicity.

According to NATAP, the initial OAR group will form a number of smaller working groups that plan to reconvene in about 6 months to discuss their findings and develop recommendations.

4/29/11

Source
National AIDS Treatment Advocacy Project. OAR Aging panel April 2011 Expert's Slide Presentation.








 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 Google Custom Search
FDA-approved HIV
and AIDS Treatments
Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide
  
Reverse Transcriptase Inhibitors NRTIs
Fixed-dose Combinations
Entry / Fusion Inhibitors EIs
Integrase Inhibitors

Experimental Treatments

CURRENT CME PROGRAMS

Noimage

Noimage

Noimage

Noimage
HIV Road Trip: Current Management Pathways and the Road Ahead

Noimage

Noimage

Noimage